Clinical Trial Update: Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy, safety and tolerability of Nangibotide in patients with septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Nangibotide (Nangibotide)

Snippet

Sponsor: Inotrem | Conditions: Shock, Septic | Phase 2 | Status: ACTIVE_NOT_RECRUITING